1[1]Wetterich U,Mutschler E.Quality of cefotaxime sodium preparations.Drug Res,1995,45:74
2[2]DI Paolo ER,Hirschi B,Pannatier A.Quantitative determination of particulate contamination in intravenous administration sets.Pharm weekbl[Sci],1990,12(5):190
3[3]Kirkpatrick CJ,Lehr HA,Bittinger F,et al.Clinical implications of circulaing particulate contamination of parenteral injections.Crit care & shockm,1999,4:166
4[4]Fujishita O,Sendo T,Hisazumi A,et al.The evaluation of sizing accuracy of particle counter for parenteral drug.J Pharmacert Sci Technol,1995,45:74
6[6]Riede UN,Joachim H,Hassenstein J,et al.The pulmonary airblood barrier of human shock lungs.(a clinical,ultrastructural and mouphometric study).Pathol Res Pract,1978,162:41
7[7]Blauth C,Arnold,Kohner EM,et al.Retinal microembolism during cardiopul bypass demonstrated by fluorescein angiography.Lancet,1986,2:837
8[8]Shaw PJ.The incidence and nature of neuralogical morbidity following cardiac surgery:a review.Perfusion,1989,4:83
9[9]Robinson LA,Braimbridge MV,Herse DJ.The potential hazard of particulate contamination of cardioplegia saltation.J Thorac Cardiovasc Surg,1984,87:48
10[10]0 Zwisslern B,Forst H,Ishii K,et al.A new experimental model of ARDS and pulmonary hypertension in the dog.Res Exp Med,1989,189:427
